Strategy for safety pharmacology studies in the course of clinical development

被引：0
|
作者：
Rochat, C. [1 ]
机构：
[1] IRIS, F-92415 Courbevoie, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2001年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [31] STUDIES ON THE CLINICAL PHARMACOLOGY OF CARBOMYCIN
    BRAINERD, HD
    KAWATA, N
    SCAPARONE, M
    ANTIBIOTICS AND CHEMOTHERAPY, 1953, 3 (09) : 925 - 929
  • [32] Clinical Pharmacology and Pharmacoepidemiology for Medication Safety in Clinical Settings
    Kawakami, Junichi
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2015, 135 (04): : 619 - 624
  • [33] Nonclinical strategy considerations for safety pharmacology: evaluation of biopharmaceuticals
    Vargas, Hugo M.
    Amouzadeh, Hamid R.
    Engwall, Michael J.
    EXPERT OPINION ON DRUG SAFETY, 2013, 12 (01) : 91 - 102
  • [34] Clinical Pharmacology in Drug Development
    Greenblatt, David J.
    Kern, Barbara A.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2012, 1 (01): : 3 - 3
  • [35] The Journal of Clinical Pharmacology, Clinical Pharmacology in Drug Development, and the Impact Factor
    Bertino, Joseph S., Jr.
    Greenblatt, David J.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (05): : 545 - 546
  • [36] The Journal of Clinical Pharmacology, Clinical Pharmacology in Drug Development, and the Impact Factor
    Bertino, Joseph S., Jr.
    Greenblatt, David J.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2017, 6 (03): : 218 - 219
  • [37] Quantitative association analyses of CNS safety pharmacology parameters to clinical observations in toxicology studies
    DaSilva, Jamie K.
    Cobbina, Enoch
    Tyszkiewicz, Cheryl
    Li, Dingzhou
    Goody, Susan
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2019, 99
  • [38] Pralatrexate Pharmacology and Clinical Development
    Marchi, Enrica
    Mangone, Michael
    Zullo, Kelly
    O'Connor, Owen A.
    CLINICAL CANCER RESEARCH, 2013, 19 (24) : 6657 - 6661
  • [39] The clinical pharmacology of antiretrovirals in development
    Winston, Alan
    Mallon, Patrick W. G.
    Boffito, Marta
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2006, 2 (03) : 447 - 458
  • [40] Clinical Pharmacology for Development of Topical Dermatological Products: Present and Future Opportunities for Safety and Efficacy
    Cho, S.
    Bashaw, E. D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (02) : 167 - 169
12345